| Product Code: ETC6660176 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Canada Lumasiran Market Overview |
3.1 Canada Country Macro Economic Indicators |
3.2 Canada Lumasiran Market Revenues & Volume, 2021 & 2031F |
3.3 Canada Lumasiran Market - Industry Life Cycle |
3.4 Canada Lumasiran Market - Porter's Five Forces |
3.5 Canada Lumasiran Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Canada Lumasiran Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Canada Lumasiran Market Revenues & Volume Share, By Dosage form, 2021 & 2031F |
3.8 Canada Lumasiran Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Canada Lumasiran Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Canada Lumasiran Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Canada Lumasiran Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of rare diseases, such as Primary Hyperoxaluria Type 1 (PH1) which can be treated with lumasiran. |
4.2.2 Growing awareness among healthcare professionals about the benefits of using lumasiran for treating rare genetic diseases. |
4.2.3 Favorable government regulations and policies supporting the development and adoption of orphan drugs like lumasiran. |
4.3 Market Restraints |
4.3.1 High cost associated with lumasiran treatment may limit affordability and access for some patients. |
4.3.2 Limited availability of healthcare facilities equipped to administer lumasiran injections. |
4.3.3 Stringent regulatory requirements and approval processes for orphan drugs like lumasiran may delay market entry and adoption. |
5 Canada Lumasiran Market Trends |
6 Canada Lumasiran Market, By Types |
6.1 Canada Lumasiran Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Canada Lumasiran Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Canada Lumasiran Market Revenues & Volume, By Miscellaneous Metabolic Agents, 2021- 2031F |
6.1.4 Canada Lumasiran Market Revenues & Volume, By others, 2021- 2031F |
6.2 Canada Lumasiran Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Canada Lumasiran Market Revenues & Volume, By Primary Hyperoxaluria, 2021- 2031F |
6.2.3 Canada Lumasiran Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Canada Lumasiran Market, By Dosage form |
6.3.1 Overview and Analysis |
6.3.2 Canada Lumasiran Market Revenues & Volume, By Injection, 2021- 2031F |
6.3.3 Canada Lumasiran Market Revenues & Volume, By Solution, 2021- 2031F |
6.4 Canada Lumasiran Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Canada Lumasiran Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.4.3 Canada Lumasiran Market Revenues & Volume, By Demographic, 2021- 2031F |
6.4.4 Canada Lumasiran Market Revenues & Volume, By Adult, 2021- 2031F |
6.4.5 Canada Lumasiran Market Revenues & Volume, By Pediatric, 2021- 2031F |
6.5 Canada Lumasiran Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Canada Lumasiran Market Revenues & Volume, By Clinics, 2021- 2031F |
6.5.3 Canada Lumasiran Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.4 Canada Lumasiran Market Revenues & Volume, By Diagnostic center, 2021- 2031F |
6.6 Canada Lumasiran Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Canada Lumasiran Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Canada Lumasiran Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 Canada Lumasiran Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Canada Lumasiran Market Import-Export Trade Statistics |
7.1 Canada Lumasiran Market Export to Major Countries |
7.2 Canada Lumasiran Market Imports from Major Countries |
8 Canada Lumasiran Market Key Performance Indicators |
8.1 Number of healthcare professionals trained in administering lumasiran injections. |
8.2 Patient enrollment in clinical trials evaluating the efficacy and safety of lumasiran. |
8.3 Adoption rate of lumasiran as a treatment option for rare genetic diseases in Canada. |
9 Canada Lumasiran Market - Opportunity Assessment |
9.1 Canada Lumasiran Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Canada Lumasiran Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Canada Lumasiran Market Opportunity Assessment, By Dosage form, 2021 & 2031F |
9.4 Canada Lumasiran Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Canada Lumasiran Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 Canada Lumasiran Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Canada Lumasiran Market - Competitive Landscape |
10.1 Canada Lumasiran Market Revenue Share, By Companies, 2024 |
10.2 Canada Lumasiran Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here